- 专利标题： Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
-
申请号： US11265517申请日： 2005-11-03
-
公开(公告)号： US20060116380A1公开(公告)日： 2006-06-01
- 发明人: Rolf Bohlmann , Martin Haberey , Andreas Huth , Stuart Ince , Martin Krueger , Karl-Heinz Thierauch , Holger Hess-Stumpp , Andreas Reichel
- 申请人： Rolf Bohlmann , Martin Haberey , Andreas Huth , Stuart Ince , Martin Krueger , Karl-Heinz Thierauch , Holger Hess-Stumpp , Andreas Reichel
- 优先权： EP04090419 20041103
- 主分类号： A61K31/506
- IPC分类号： A61K31/506 ; A61K31/501 ; A61K31/4709 ; A61K31/497 ; A61K31/444 ; C07D403/14 ; C07D401/14
摘要：
The invention relates to novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.